Laager Left Atrial Appendage Occlusion System: Prospective Multicenter Safety and Efficacy Study i

Study objective and publication details

This article reports a clinical evaluation of the Laager left atrial appendage occlusion system in patients with atrial fibrillation, with the stated objective to investigate the device's safety and efficacy for stroke prevention. The citation details available on PubMed are: Zhonghua Xin Xue Guan Bing Za Zhi. 2026 Aug 24;54(8):967-973. PMID: 42595523. DOI: 10.3760/cma.j.cn112148-20260306-00144.

Both Chinese and English abstracts are indexed on PubMed. The article is presented as a multicenter clinical study. A link to the full text on the Chinese Medical Association Publishing House site is provided in the PubMed entry.

Study design and patient population (reported)

The study is described in the indexed abstract as a prospective, multicenter, non-randomized, single-arm cohort study. That design indicates all enrolled patients received the investigational Laager left atrial appendage occlusion system and there was no randomized comparison group.

The supplied PubMed content confirms the primary therapeutic goal — stroke prevention in patients with atrial fibrillation — and identifies the study design. No further details about the number of enrolled patients, eligibility criteria (for example, CHA2DS2-VASc or HAS-BLED thresholds), baseline demographics, or the spectrum of atrial fibrillation (paroxysmal, persistent, permanent) are provided in the source text available for this rewrite.

Available authors and institutional affiliations

The article lists M Y Ding et al. as authors with multiple coauthors. The study is a multicenter collaboration involving at least 12 cardiology departments across China, including but not limited to:

• Department of Cardiology, State Key Laboratory of Frigid Zone Cardiovascular Disease, General Hospital of Northern Theater Command, Shenyang
• Shaw Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou
• Tianjin Medical University General Hospital, Tianjin
• Jiangsu Province Hospital, Nanjing
• Shanghai Pudong New Area Zhoupu Hospital
• Nanfang Hospital, Southern Medical University, Guangzhou
• Shanghai Sixth People's Hospital
• Hebei General Hospital, Shijiazhuang
• Zhengzhou No.7 People's Hospital
• The First Affiliated Hospital of Dalian Medical University
• Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
• Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

These institutional affiliations indicate broad clinical site participation and likely reflect enrollment across tertiary cardiac centers.

What is not reported in the supplied source (missing methods and results)

The PubMed content provided for this task includes only the study objective and primary design. Critical methodological and outcome details were not included in the supplied source text. Specifically missing from the supplied material are:

• Number of patients enrolled and analyzed.
• Inclusion and exclusion criteria.
• Procedural details (implant technique, access route, periprocedural anticoagulation or antiplatelet regimen).
• Device specifications, sizing algorithm, and available configurations of the Laager occlusion system.
• Primary and secondary endpoints, including definitions (for example, device success, procedural success, periprocedural complications, stroke, systemic embolism, major bleeding).
• Quantitative safety outcomes (rates of device-related thrombus, pericardial effusion/tamponade, vascular complications, procedural mortality).
• Quantitative efficacy outcomes (incidence of ischemic stroke, systemic embolism, all-cause mortality) and time points for follow-up.
• Duration of follow-up and completeness of follow-up reporting.
• Statistical analysis plan, power calculations, and handling of missing data.
• Authors' conclusions or recommendations based on reported outcomes.

Because these elements were not included in the supplied PubMed excerpt, no efficacy or safety results can be restated here without consulting the full-text article.

Where to find the full text and language note

The PubMed entry provides a link to the full text at the Chinese Medical Association Publishing House (link indicated in the record). The article is reported as being in Chinese; both Chinese and English abstracts are indexed. Clinicians or reviewers seeking complete data, numeric results, and the authors' conclusions should consult the full text. If language is a barrier, obtaining a professional translation or the English abstract in PubMed may help determine whether a full translation is required.

Implications and recommended next steps for clinicians

From the supplied PubMed record we can confirm that a formal prospective multicenter evaluation of the Laager left atrial appendage occlusion system has been conducted and reported. However, because the supplied source does not include methods, outcomes, or the authors' conclusions, clinicians should:

• Review the full-text article to assess the device's procedural success, safety events, and clinical efficacy endpoints over the reported follow-up period.
• Examine patient selection criteria and periprocedural medical management to determine comparability with their own practice population.
• Consider the level of evidence (single-arm, non-randomized) when weighing the findings against randomized trials and established devices for left atrial appendage occlusion.
• Look for subsequent peer commentary, independent registry data, or randomized comparisons before changing practice based solely on this single-arm study.

Limitations of this summary: the source material provided for this rewrite contained only the article metadata and the opening statement of the abstract. No numerical results, safety signals, or final conclusions were available in the supplied text; therefore this document refrains from inferring outcomes or making clinical claims beyond what is explicitly indexed on PubMed. To access complete study details, consult the full text (Chinese) via the link provided in the PubMed record or obtain a translation if required.